D Cook Selected Research

D Cook Research Topics

6	Infections 01/2008 - 09/2000
4	Hemorrhage 12/2013 - 12/2001
3	Critical Illness (Critically Ill) 06/2009 - 03/2001
3	Chronic Obstructive Pulmonary Disease (COPD) 12/2001 - 06/2000
2	Hepatitis C 01/2017 - 03/2009
2	Neoplasms (Cancer) 01/2017 - 07/2007
2	Renal Insufficiency (Renal Failure) 12/2013 - 06/2009
2	Poisoning 07/2012 - 01/2008
2	Wounds and Injuries (Trauma) 12/2001 - 12/2001
2	Sepsis (Septicemia) 04/2001 - 03/2000
2	Respiratory Insufficiency (Respiratory Failure) 10/2000 - 06/2000
1	Aspiration Pneumonia 05/2020
1	Heart Arrest (Cardiac Arrest) 05/2020
1	Coinfection 01/2017
1	Hepatitis 01/2017
1	Hepatitis B 01/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Tuberculosis (Tuberculoses) 01/2017
1	Muscle Weakness 08/2015
1	Morbid Obesity 12/2013
1	Combined Pituitary Hormone Deficiency 06/2013
1	cyclopia sequence 07/2009
1	Congenital Abnormalities (Deformity) 07/2009
1	Thrombosis (Thrombus) 07/2007
1	Thrombocytopenia (Thrombopenia) 07/2007
1	Persistent Vegetative State (Vegetative State) 03/2006
1	Brain Death (Brain Dead) 03/2006
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2005
1	Vitamin K Deficiency 01/2002
1	Necrotizing Fasciitis 12/2001
1	Constipation 06/2001
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 04/2001
1	Embolism (Embolus) 12/2000
1	Venous Thrombosis (Deep-Vein Thrombosis) 12/2000
1	Bacteremia 09/2000
1	Neutropenia 09/2000
1	Agammaglobulinemia (Hypogammaglobulinemia) 09/2000
1	Nocardia Infections 09/2000
1	Respiratory Acidosis 06/2000
1	Ulcer 03/2000

4	AlkaloidsIBA 08/2015 - 01/2008
3	Pharmaceutical PreparationsIBA 01/2017 - 04/2001
3	Heparin (Liquaemin)FDA LinkGeneric 12/2013 - 12/2001
2	AnticoagulantsIBA 07/2007 - 12/2000
2	Vitamin K FDA Link 07/2007 - 01/2002
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 07/2007 - 12/2001
1	Oxygen (Dioxygen)IBA 05/2020
1	Prescription DrugsIBA 01/2017
1	InterferonsIBA 01/2017
1	Insulin-Like Growth Factor I (IGF-1)IBA 06/2013
1	cyclopamineIBA 07/2009
1	Dalteparin (Dalteparin Sodium)FDA Link 06/2009
1	SwainsonineIBA 01/2008
1	ximelagatran (Exanta)IBA 07/2007
1	Fondaparinux (Arixtra)FDA Link 07/2007
1	Busulfan (Busulfex)FDA Link 02/2005
1	Prothrombin (Factor II)IBA 01/2002
1	fibrin fragment D (D-dimer)IBA 01/2002
1	Substance PIBA 06/2001
1	nodulinIBA 05/2001
1	Biomarkers (Surrogate Marker)IBA 04/2001
1	Therapeutic UsesIBA 03/2001
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2000
1	CalciumIBA 11/2000
1	Tacrolimus (Prograf)FDA LinkGeneric 09/2000
1	Muromonab-CD3 (Muromonab CD3)FDA Link 09/2000
1	Azathioprine (Imuran)FDA LinkGeneric 09/2000
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2000
1	Immunoglobulin G (IgG)IBA 09/2000
1	Immunosuppressive Agents (Immunosuppressants)IBA 09/2000
1	Prednisone (Sone)FDA LinkGeneric 09/2000
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 09/2000

3	Therapeutics 01/2001 - 06/2000
2	Noninvasive Ventilation 12/2001 - 06/2000
2	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 10/2000 - 06/2000
1	Tracheostomy 05/2020
1	Opiate Substitution Treatment 01/2017
1	Catheters 12/2013
1	Treatment Delay 07/2007
1	Central Venous Catheters 07/2007
1	Euthanasia (Mercy Killing) 03/2006
1	Intermittent Pneumatic Compression Devices 12/2001
1	Operative Surgical Procedures 12/2001
1	Critical Care (Surgical Intensive Care) 04/2001
1	Organ Transplantation 09/2000
1	Artificial Respiration (Mechanical Ventilation) 03/2000
1	Blood Transfusion (Blood Transfusions) 03/2000
1	Immunotherapy 03/2000